Related Experiment Video
Updated: Jun 4, 2025

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
ATRX loss inhibits DDR to strengthen radio-sensitization in p53-deficent HCT116 cells
Lijing Qin1, Geng Tang1, Ruirui Gui1
1NHC Key Laboratory of Radiobiology (Jilin University), School of Public Health, Jilin University, Changchun, 130021, Jilin, People's Republic of China.
Abstract:
Identifying novel targets for molecular radiosensitization is critical for improving the efficacy of colorectal cancer (CRC) radiotherapy. Alpha-thalassemia/mental retardation X-linked (ATRX), a member of the SWI/SNF-like chromatin remodeling protein family, functions in the maintenance of genomic integrity and the regulation of apoptosis and senescence. However, whether ATRX is directly involved in the radiosensitivity of CRC remains unclear. Our results showed that silencing ATRX increased the radiosensitivity of HCT116 CRC cells, which was further strengthened when p53 was depleted. To explore the potential mechanism, we focused on the impact of the ionizing radiation (IR)-induced DNA damage response (DDR), apoptosis, and senescence and the activation of the Daxx/MDM2/p53 pathway caused by ATRX loss. The results showed that IR induced DNA damage and G2/M arrest after depleting ATRX, especially in p53-depleted HCT116 cells, and inhibited ATM/Chk2 pathway activation, indicating that ATRX loss leads to failure of triggering the ATM/Chk2 pathway. Accordingly, ATRX loss promotes cell apoptosis and attenuates cell senescence. Interestingly, our results indicate that ATRX loss upregulates p53 function via the Daxx/MDM2 pathway to mediate radiosensitivity. Thus, ATRX may represent a novel radiosensitizing target for CRC, particularly p53-deficient CRC.
Insights
Alpha-thalassemia/mental retardation X-linked (ATRX) silencing enhances colorectal cancer (CRC) cell radiosensitivity, particularly when p53 is depleted. ATRX loss promotes apoptosis and DNA damage response, suggesting ATRX as a radiosensitizing target.
Area of Science:
- Oncology
- Molecular Biology
- Radiotherapy
Background:
- Radiotherapy is a cornerstone of colorectal cancer (CRC) treatment, but resistance limits efficacy.
- Identifying novel molecular targets for radiosensitization is crucial for improving patient outcomes.
- Alpha-thalassemia/mental retardation X-linked (ATRX) is a chromatin remodeler involved in genomic stability, but its role in CRC radiosensitivity is unknown.
Purpose of the Study:
- To investigate the role of ATRX in the radiosensitivity of colorectal cancer (CRC) cells.
- To elucidate the underlying molecular mechanisms by which ATRX influences response to ionizing radiation (IR).
Main Methods:
- Silencing of ATRX in HCT116 CRC cells using shRNA.
- Irradiation of cells and assessment of DNA damage response (DDR), apoptosis, and senescence.
- Analysis of the Daxx/MDM2/p53 pathway activation and ATM/Chk2 signaling.
Main Results:
- ATRX depletion significantly increased radiosensitivity in HCT116 CRC cells, an effect amplified by p53 depletion.
- ATRX loss led to IR-induced DNA damage and G2/M arrest, with impaired ATM/Chk2 pathway activation.
- ATRX deficiency promoted apoptosis and attenuated senescence, mediated by upregulation of p53 function via the Daxx/MDM2 pathway.
Conclusions:
- ATRX plays a critical role in regulating colorectal cancer cell radiosensitivity.
- ATRX loss impairs the DNA damage response and promotes apoptosis, enhancing radiosensitivity.
- ATRX represents a potential novel radiosensitizing target for CRC, especially in p53-deficient tumors.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
The Intrinsic Apoptotic Pathway
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

